CI Investments Inc
CORT icon

CI Investments Inc’s Corcept Therapeutics CORT Stock Holding History

CI Investments Inc’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-860
Closed -$71K – 780
2025
Q3 		$71K Sell
860
-674
-44% -$48.8K ﹤0.01% 947
2025
Q2 		$113K Buy
1,534
+1,404
+1,080% +$102K ﹤0.01% 881
2025
Q1 		$15K Sell
130
-52
-29% -$3.17K ﹤0.01% 1209
2024
Q4 		$9K Buy
+182
New +$9.54K ﹤0.01% 1250
2024
Q2 		– Sell
-6,400
Closed -$161K – 1272
2024
Q1 		$161K Buy
6,400
+499
+8% +$11.8K ﹤0.01% 763
2023
Q4 		$192K Buy
5,901
+1,167
+25% +$32K ﹤0.01% 660
2023
Q3 		$129K Buy
+4,734
New +$137K ﹤0.01% 767

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CI Investments Inc's CORT Position: Q4 2025 in Review

CI Investments Inc sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 860 shares — an estimated $71K sold.

CI Investments Inc first reported a position in CORT in Q3 2023 and held it in 7 quarters. The position peaked at $192K in Q4 2023. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • CI Investments Inc reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 860 Corcept Therapeutics shares in Q4 2025, an estimated $71K.
  • CI Investments Inc first reported a position in Corcept Therapeutics in Q3 2023 and held it in 7 quarters.
  • CI Investments Inc's Corcept Therapeutics position peaked at $192K in Q4 2023.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.